Table 4 Factors associated with HCC recurrence.
HCC recurrence (+) (n = 22) | HCC recurrence (−) (n = 149) | P value | HR | C.I. | P value | |
|---|---|---|---|---|---|---|
Age (years, mean ± SD) | 61.9 ± 11.9 | 62.7 ± 11.4 | 0.76 | |||
Male gender, n (%) | 20 (90.9) | 110 (73.8) | 0.09 | |||
BMI (kg/m2, mean ± SD) | 23.7 ± 3.6 | 25.0 ± 4.6 | 0.22 | |||
AST (IU/L, mean ± SD) | 61 ± 41 | 55 ± 37 | 0.49 | |||
ALT (IU/L, mean ± SD) | 61 ± 43 | 51 ± 40 | 0.29 | |||
α-fetoprotein >20 ng/mL, n (%) | 9 (42.9) | 62 (42.8) | 0.84 | |||
Fibrosis stage 3–4, n (%) | 12 (54.5) | 80 (53.7) | 1 | |||
Child-Pugh score A, n (%) | 18 (85.7) | 128 (90.1) | 0.45 | |||
MICA rs2596542 A allele, n (%) | 12 (54.5) | 65 (45.5) | 0.30 | |||
Tumor MICA expression* <30%, n (%) | 15 (68.2) | 71 (47.7) | 0.04 | 2.77 | 1.07–7.14 | 0.035 |
BCLC stage 0-A, n (%) | 7 (31.8) | 101 (67.8) | <0.001 | |||
TMN stage 1, n (%) | 3 (13.6) | 60 (40.3) | 0.01 | |||
Tumor size >5 cm, n (%) | 15 (68.2) | 44 (29.5) | <0.001 | 5.22 | 2.11–12.96 | <0.001 |
Tumor number >2, n (%) | 5 (22.7) | 22 (14.8) | 0.32 |